OCUL
Ocular Therapeutix, Inc. · Healthcare
President and CEO Antony C. Mattessich sold $91K of Ocular Therapeutix, Inc.
Sold$90,773
$4.95Price
18,338Shares
−4%Stake
What OCUL did after the filing
- The stock from Fri, Feb 2 close, $5.18
- +82.2%
- S&P 500, same days
- +4.1%
Measured over 30 trading days, to the Mar 18 close.
Traded Wed, Jan 31. Filed Fri, Feb 2, 2:00 PM ET, during the session. Returns use the Feb 2 close and the Mar 18 close. Not investment advice.